Research and Development Team

The Research and Development Team at Kymab is dedicated to the discovery and advancement of fully human monoclonal antibody drugs. Leveraging the company’s proprietary antibody platform, they conduct cutting-edge research, preclinical studies, and translational biology efforts to develop novel therapies for infectious diseases and other medical conditions. This team collaborates to ensure Kymab’s therapies are innovative and effective, contributing to the company’s mission of improving global health outcomes.